Soviets used it to support cancer care. 1,600 studies. Zero US trials. Why?

???? The Nature’s Lost Vault Book Is Now Available. Learn more: https://naturelostvault.com/book.html

A Nobel Prize-winning author survived cancer and wrote about the remedy. The Soviet government banned his book. The USSR's own Ministry of Health had already approved it as a pharmaceutical. That remedy is still prescribed in Russia, Poland, and across Eastern Europe today.

In America, the FDA has never funded a single human trial. In 2017, they issued a formal warning letter to a company that dared cite the documented biological mechanism in their marketing. Over 1,600 peer-reviewed papers confirming the science were not enough. The molecule cannot be patented. The fungus cannot be owned. And that, it turns out, is the only standard that matters.

This vault covers the 1,000-year history of chaga mushroom, the documented Soviet pharmaceutical approval of 1955, the FDA suppression mechanism that keeps unpatentable natural compounds permanently outside clinical medicine, and the peer-reviewed research showing 60% tumor reduction, selective cancer cell apoptosis, and synergistic effects with conventional chemotherapy. It also covers where chaga grows wild across North America, how to identify and harvest it sustainably, and how to brew it the same way the Khanty people of Western Siberia have for a thousand years.

The knowledge was never lost. It is growing in every mature birch forest in the North. What was taken was the permission to know about it.

???? Sources:

- Géry, Antoine, et al. "Chaga (Inonotus obliquus), a Future Potential Medicinal Fungus in Oncology?" Integrative Cancer Therapies 17.3 (2018): 832-843.
- Arata, Suguru, et al. "Continuous Intake of the Chaga Mushroom Suppresses Cancer Progression and Maintains Body Temperature in Mice." Heliyon 2.5 (2016): e00111.
- Szychowski, Konrad A., et al. "Inonotus obliquus: From Folk Medicine to Clinical Use." Journal of Traditional and Complementary Medicine 11.1 (2021): 59-67.
- Chung, Min-Ju, et al. "Chaga Mushroom Triterpenoids as Adjuncts to Minimally Invasive Cancer Therapies: A Review." PMC (2023).
- Nasser, Mona, et al. "Chaga Mushroom Triterpenoids Inhibit Dihydrofolate Reductase and Act Synergistically with Conventional Therapies in Breast Cancer." Biomolecules 14.11 (2024): 1454.
- Shashkina, M.Y., Shashkin, P.N., and Sergeev, A.V. "Chemical and Medicobiological Properties of Chaga (Review)." Pharmaceutical Chemistry Journal 40.10 (2006): 560-568.
- Solzhenitsyn, Aleksandr. Cancer Ward. Trans. Nicholas Bethell and David Burg. New York: Farrar, Straus and Giroux, 1968.
- Memorial Sloan Kettering Cancer Center. "Chaga Mushroom." Integrative Medicine herb profile, 2024.
- U.S. Food and Drug Administration. Warning Letter 513213 to Healing Within Products and Services, Inc. April 17, 2017.
- Karpiński, Tomasz M., and Omar M. Atrooz. "A Brief Overview of the Medicinal and Nutraceutical Importance of Inonotus obliquus (Chaga) Mushrooms." Heliyon 10.15 (2024).

#forgottenremedies #ancientwisdom #medicinalmushrooms #foraging #naturalhealing